Inhibrx Biosciences, Inc.

1. 01

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $86.76 was 13.7% below its 50-day average ($100.52) and 6.0% below its 200-day average ($92.25). It has closed below the 200-day for 6 sessions, since 28 Oct 2026. The 50-day average crossed above the 200-day on 14 Jul 2025, 331 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

2. 02

   16.8 days to cover short interest

   3.4M shares were sold short at the 15 Oct 2026 settlement, 23.2% of the 14.7M shares outstanding; covering them would take 16.8 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

3. 03

   Behind SPY and its sector fund XLV over 1 year

   1 month: −7.1% (SPY −1.6%, XLV +13.5%). 3 months: +3.4% (SPY −0.4%, XLV +15.5%). 1 year: +5.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: INBX, SPY and XLV · as of 4 Nov 2026

4. 04

   Volume 2.2× its 30-session average on 3 Nov 2026

   3 Nov 2026 volume of 600.2K shares was 2.2× the average of the 30 sessions before it (274.7K), as the price rose 12.4%. SPY traded 0.8× its own average that session.

   Daily volume against a 30-session baseline · as of 3 Nov 2026

5. 05

   30% of the way up its 52-week range

   Closed at $86.76 on 4 Nov 2026: 44.1% below the 52-week high of $155.29 (22 Apr 2026) and 51.4% above the low of $57.30 (27 Mar 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

At the 4 Nov 2026 close